Study Identifiers
Protocol number and sponsor contact appear at the top to link the instruction to the correct trial and reporting channels.
Clear instructions reduce protocol deviations, improve participant safety, and create an auditable record for sponsors and institutional review boards. They support consistency across sites, speed training, and help meet regulatory expectations for documentation and traceability under HIPAA and applicable federal standards.
This document is used by clinical site staff, investigators, sponsors, and participants to coordinate trial activities and document consent or procedural steps.
Knowing who completes which sections helps assign responsibilities and ensures each required signature and record is captured correctly.
| Field | Configuration | Role | Permission | Required |
|---|---|
| Template | Preload instruction text and required fields for each visit |
| Signer Authentication | Email plus SMS OTP for staff; stronger KBA for participant identity where required |
| Conditional Fields | Show adverse-event sections only if checkbox selected |
| Audit Trail Storage | Retain signed PDF and metadata for regulatory inspection |
Choose a platform that supports HIPAA workflows, audit trails, and the integrations your sites use.
Protocol number and sponsor contact appear at the top to link the instruction to the correct trial and reporting channels.
One-paragraph summary explains what the instruction covers and when it applies during the participant pathway.
Numbered steps specify who performs each action, required timing windows, and sample handling instructions when applicable.
Clear directions for reporting adverse events, including timelines and sponsor or IRB contact details.
Designated signer fields capture role, printed name, electronic signature, and timestamp for auditability.
Include related forms, lab shipping labels, and checklists as embedded exhibits to prevent omission.
Instruction must be finalized and approved by the IRB prior to participant enrollment.
Participant must sign instructions or consent prior to any study-specific interventions.
Report serious events per sponsor and IRB timelines, often within 24 to 72 hours.
Retention begins on execution date of the signed instruction.
Notify sites and reconsent participants as required by the IRB within sponsor timelines.
A clinical practice standardized its patient instruction for sample collection and consent
A hospital research unit implemented a central instruction template for multicenter trials
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Trial available | Trial available | Trial available | Trial available |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |